OMB Trademark

Trademark Overview

On Monday, December 14, 2020, a trademark application was filed for OMB with the United States Patent and Trademark Office. The USPTO has given the OMB trademark a serial number of 90380256. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by Novartis AG. The OMB trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations acting on the central nervous system
omb

General Information

Serial Number90380256
Word MarkOMB
Filing DateMonday, December 14, 2020
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7115849
Registration DateTuesday, July 18, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements

Description of MarkThe mark consists of two transverse stripes, one teal and one coral, applied side by side near the middle of a three-dimensional injection pen; the teal stripe is plain, the coral stripe is inscribed with a series of small stylized arrows pointing in one direction bordered by one and a half rounded white arrows pointing in the other direction; the logo OMB, with the "O" in coral and the combined letters "MB" in teal, appears one inch below the teal stripe; the dotted lines are for placement only and are not a part of the mark.
Goods and Servicespharmaceutical preparations acting on the central nervous system
Indication of Colors claimedThe color(s) teal, coral, and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 22, 2021
Primary Code005
First Use Anywhere DateThursday, October 1, 2020
First Use In Commerce DateThursday, October 1, 2020

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events

Event DateEvent Description
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER
Friday, June 16, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 15, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 30, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, May 5, 2023USE AMENDMENT FILED
Tuesday, May 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 5, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 27, 2022SOU EXTENSION 2 GRANTED
Sunday, November 27, 2022SOU EXTENSION 2 FILED
Sunday, November 27, 2022TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 22, 2022SOU EXTENSION 1 GRANTED
Sunday, May 22, 2022SOU EXTENSION 1 FILED
Sunday, May 22, 2022TEAS EXTENSION RECEIVED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 24, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 24, 2021NON-FINAL ACTION E-MAILED
Thursday, June 24, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 7, 2021NON-FINAL ACTION E-MAILED
Monday, June 7, 2021NON-FINAL ACTION WRITTEN
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2020NEW APPLICATION ENTERED

Related Keywords

nervous system central acting preparations pharmaceutical